Literature DB >> 25404718

Recalcitrant hypocalcaemia in autoimmune enteropathy.

Myfanwy Geyer1, Jan Fairchild2, David Moore3, Lynette Moore4, Paul Henning5, Elaine Tham2.   

Abstract

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy syndrome is a monogenic disorder associated with autoimmune destruction of both endocrine and nonendocrine tissues. The classic triad includes candidiasis, hypoparathyroidism, and Addison disease. Up to 25% of patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy syndrome also have gastrointestinal manifestations, which can have an impact on the management of other aspects of the disease. The management of the case discussed was challenging because of the complex interplay between the manifestations and treatment of his hypoparathyroidism, Addison disease, and autoimmune enteropathy. Attempts at management of hypocalcemia were largely unsuccessful until the introduction of immunosuppressive therapy for autoimmune enteropathy. This case supports early consideration of immunosuppression in this condition.
Copyright © 2014 by the American Academy of Pediatrics.

Entities:  

Keywords:  APECED; APS-1; autoimmune enteropathy; autoimmune polyendocrinopathy candidiasis ectodermal dystrophy syndrome; autoimmune polyendocrinopathy syndrome 1; enteroendocrine cells; hypocalcaemia

Mesh:

Substances:

Year:  2014        PMID: 25404718     DOI: 10.1542/peds.2013-3308

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  3 in total

Review 1.  [Polyglandular autoimmune syndromes : An overview].

Authors:  P Komminoth
Journal:  Pathologe       Date:  2016-05       Impact factor: 1.011

Review 2.  Autoimmune enteropathies.

Authors:  Sarah E Umetsu; Ian Brown; Cord Langner; Gregory Y Lauwers
Journal:  Virchows Arch       Date:  2017-10-11       Impact factor: 4.064

3.  Case Report: Severe Hypocalcemic Episodes Due to Autoimmune Enteropathy.

Authors:  Inbal Halabi; Marie Noufi Barohom; Sarit Peleg; Phillippe Trougouboff; Ghadir Elias-Assad; Rhania Agbaria; Yardena Tenenbaum-Rakover
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-14       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.